Inovio Pharmaceuticals Inc. (INO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.48
    0.05 (2.06%)
    At close: Sep 26, 2025, 3:59 PM
    2.47
    -0.38%
    After-hours: Sep 26, 2025, 06:49 PM EDT

    Inovio Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.46 -1 -1.33 -42.32
    PEG Ratio
    		 0.01 0.02 -0.00 -1.29
    PS Ratio
    		 228.26 163.10 36.27 7.24K
    PB Ratio
    		 0.73 1.16 1.67 32.16
    P/FCF Ratio
    		 -0.48 -1.09 -1.71 -59.24
    P/OCF Ratio
    		 -0.48 -1.09 -1.72 -59.58
    OCF/S Ratio
    		 -477.95 -149.48 -21.07 -121.54
    Debt / Equity Ratio
    		 0.17 0.26 0.14 0.08
    Quick Ratio
    		 2.77 3.60 3.25 6.82
    Current Ratio
    		 2.77 3.60 3.25 6.82
    Asset Turnover
    		 0.00 0.00 0.03 0.00
    Interest Coverage
    		 -632.05 -117.71 -213.38 -155.55
    Return on Equity
    		 -1.57 -1.15 -1.26 -0.76
    Return on Assets
    		 -0.95 -0.79 -0.8 -0.61
    Return on Invested Capital
    		 n/a -0.98 -1.05 -0.69
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -13.37 -3.21 0.46 -1.67
    Net Profit Margin
    		 -492.54 -162.4 -27.27 -171.1
    Pretax Profit Margin
    		 -492.54K -162.4 -27.06 -170.85
    Operating Profit Margin
    		 -516.17 -173 -26.07 -169.72
    FCF Margin
    		 -480.19 -149.86 -21.16 -122.24
    EBITDA Margin
    		 -477.35 -156.72 -26.4 -167.1

    Add to Watchlist